H Ishida
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 16
- Colorectal Cancer Treatments and Studies 4
- Pancreatic and Hepatic Oncology Research 4
- Epidemiology 14
- Liver Disease Diagnosis and Treatment 6
- Co-authors
- Yuzuru Takemura (7 shared papers)Yoshiharu Yonekura (1 shared paper)Yuji Suzuki (1 shared paper)H Kanamaru (1 shared paper)Nobuyuki Oyama (1 shared paper)Norihiro Sadato (1 shared paper)Hironobu Akino (1 shared paper)K Okada (1 shared paper)
- Journals
- Clinical Chemistry (5 papers)Japanese Journal of Clinical Oncology (2 papers)PLoS ONE (2 papers)Clinica Chimica Acta (2 papers)Value in Health (2 papers)
- Partner nations
- JapanUnited States
In The Last Decade
H Ishida
44 papers receiving 510 citations
Peers
Comparison fields: 5 of 91
- Applied Microbiology and Biotechnology 25
- Hepatology 67
- Pharmacy 30
- Oncology 146
- Radiology, Nuclear Medicine and Imaging 99
Countries citing papers authored by H Ishida
This map shows the geographic impact of H Ishida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Ishida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Ishida more than expected).
Fields of papers citing papers by H Ishida
This network shows the impact of papers produced by H Ishida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Ishida. The network helps show where H Ishida may publish in the future.
Co-authors
The 25 scholars most cited alongside H Ishida, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 88 | |
| 2 | 2000 | 59 | |
| 3 | Guideline for economic evaluation of healthcare technologies in Japan | 2013 | 46 |
| 4 | 2002 | 46 | |
| 5 | 1995 | 45 | |
| 6 | 1993 | 32 | |
| 7 | Evaluation of combined therapy with chemoembolization and ethanol injection for advanced hepatocellular carcinoma. | 1997 | 23 |
| 8 | 2008 | 20 | |
| 9 | 2000 | 18 | |
| 10 | 2005 | 16 | |
| 11 | 1999 | 14 | |
| 12 | 1984 | 13 | |
| 13 | 2002 | 13 | |
| 14 | 2001 | 11 | |
| 15 | 2004 | 10 | |
| 16 | 2005 | 9 | |
| 17 | 2003 | 9 | |
| 18 | [Evaluation of diagnostic performance of alpha-fetoprotein (AFP) and des-gamma-carboxy prothrombin (DCP) for HCV related hepatocellular carcinoma developed after long-term follow up]. | 2010 | 9 |
| 19 | 2000 | 7 | |
| 20 | 2007 | 6 |
About H Ishida
H Ishida is a scholar working on Oncology, Epidemiology, Hepatology, Pulmonary and Respiratory Medicine and Surgery, having authored 46 papers that have together received 541 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Hepatitis C virus research (7 papers), Liver Disease Diagnosis and Treatment (6 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers), Clinical Laboratory Practices and Quality Control (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Healthcare cost, quality, practices (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (25 citations), Hepatology (67 citations), Pharmacy (30 citations), Oncology (146 citations) and Radiology, Nuclear Medicine and Imaging (99 citations). H Ishida has collaborated with scholars based in Japan and United States. Frequent co-authors include Yuzuru Takemura, Yoshiharu Yonekura, Yuji Suzuki, H Kanamaru, Nobuyuki Oyama, Norihiro Sadato, Hironobu Akino, K Okada, Kazuya Tanase and Masami Ishibashi. Their work appears in journals such as Clinical Chemistry, Japanese Journal of Clinical Oncology, PLoS ONE, Clinica Chimica Acta and Value in Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.